KPS AG (KSCd)

Overview

Lipidor AB (publ), headquartered in Danderyd, Sweden, is a pioneering pharmaceutical development company focusing on the creation of novel treatments for a variety of skin conditions. Since its inception in 2009, Lipidor has committed itself to addressing the therapeutic needs of patients suffering from psoriasis, acne vulgaris, bacterial skin infections, and atopic dermatitis. By advancing both preclinical and clinical-stage products, Lipidor aims to bring innovative solutions to the market. The company leverages a robust product pipeline, highlighted by its flagship AKP-01 treatment for psoriasis currently in Phase III development. With a strategic collaboration with Cannassure Therapeutics Ltd., Lipidor is expanding its horizon into the development of topical medicinal cannabis products, targeting skin inflammations and psoriatic lesions, underscoring its commitment to addressing unmet medical needs through cutting-edge research and development.

Products and Services

• AKP-01 (Psoriasis Treatment)

  In active Phase III development, AKP-01 represents Lipidor's frontline treatment for psoriasis, showcasing the company's dedicated research in addressing chronic skin conditions with innovative therapeutic options.

• Preclinical Stage Products

  - AKP-02 for Psoriasis: A promising candidate aimed at expanding Lipidor's psoriasis treatment portfolio.
  - AKP-03 for Bacterial Skin Diseases: Targeting a wide range of bacterial skin infections with a novel approach.
  - AKP-07 for Atopic Dermatitis: Focused on treating the challenging condition of atopic dermatitis, providing new hope for patients.

• Active Pharmaceutical Ingredients (APIs)

  Lipidor offers a diverse range of APIs used in various therapeutic applications. These include anti-psoriasic, antimicrobial, anti-inflammatory, antifungal, local anesthetics, non-steroidal anti-inflammatory, anti-acne, wound healing, anti-eczema, and anti-migraine formulations, catering to a broad spectrum of healthcare needs.

• Consumer Healthcare and Animal Skin Care

  Beyond pharmaceuticals for human healthcare, Lipidor extends its innovation to consumer health care products and animal skin care solutions. These offerings cover antibacterial, antiseptic, moisturizing emollient, disinfectant, acne and wart treatment for personal care, as well as specialized spray products for the skin care of dogs, cats, and horses, reflecting Lipidor's holistic approach to skin health.

• Collaborative Development with Cannassure Therapeutics Ltd.

  Embarking on a collaboration with Cannassure Therapeutics Ltd., Lipidor is venturing into the development of topical medicinal cannabis products. This initiative specifically targets the treatment of skin inflammations and psoriatic lesions, illustrating Lipidor's strategic focus on leveraging partnerships to explore new therapeutic frontiers.